Dyne Therapeutics, Inc.
DYN
DELAYED 1 MONTH
24 insider filings · Latest: Jul 27, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | Jul 29 8:15 PM | Dirk KerstenDirector | Sale | 261,460 | $25.51 | $6.7M | 3,586,796(I) | View → |
| Jun 8, 2026 | Jun 9 9:06 PM | Brian S PosnerDirector | Purchase | 2,000 | $16.94 | $33.9K | 24,500(D) | View → |
| Jun 3, 2026 | Jun 5 8:10 PM | Brian S PosnerDirector | Purchase | 2,500 | $17.48 | $43.7K | 22,500(D) | View → |
| May 26, 2026 | May 28 8:11 PM | Brian S PosnerDirector | Purchase | 2,000 | $18.21 | $36.4K | 20,000(D) | View → |
| May 20, 2026 | May 22 8:10 PM | Brian S PosnerDirector | Purchase | 2,500 | $17.12 | $42.8K | 18,000(D) | View → |
| May 13, 2026 | May 14 8:05 PM | Johanna Friedl-NadererChief Commercial Officer | Sale | 228 | $18.36 | $4.2K | 154,353(D) | View → |
| May 13, 2026 | May 14 8:04 PM | Douglas KerrChief Medical Officer | Sale | 1,564 | $18.36 | $28.7K | 170,042(D) | View → |
| May 13, 2026 | May 14 8:03 PM | Erick LuceraChief Financial Officer | Sale | 1,448 | $18.36 | $26.6K | 123,925(D) | View → |
| May 13, 2026 | May 14 8:02 PM | John CoxDirector, CEO & President | Sale | 3,311 | $18.36 | $60.8K | 370,834(D) | View → |
| May 6, 2026 | May 6 9:09 PM | Jason P RhodesDirector | Sale | 83,219 | $18.18 | $1.5M | 1,136,810(I) | View → |
| May 5, 2026 | May 6 9:09 PM | Jason P RhodesDirector | Sale | 11,600 | $18.03 | $209.1K | 1,154,054(I) | View → |
| May 4, 2026 | May 6 9:09 PM | Jason P RhodesDirector | Sale | 11,904 | $18.00 | $214.3K | 1,156,457(I) | View → |
| Apr 28, 2026 | Apr 30 9:22 PM | Jason P RhodesDirector | Sale | 227,337 | $18.38 | $4.2M | 1,158,923(I) | View → |
| Mar 11, 2026 | Mar 13 8:46 PM | Brian S PosnerDirector | Purchase | 2,000 | $19.35 | $38.7K | 13,500(D) | View → |
| Mar 11, 2026 | Mar 13 8:35 PM | Dirk KerstenDirector | Sale | 129,672 | $19.52 | $2.5M | 4,644,386(I) | View → |
| Mar 10, 2026 | Mar 11 9:27 PM | Dirk KerstenDirector | Sale | 511,098 | $19.57 | $10.0M | 4,774,058(I) | View → |
| Mar 9, 2026 | Mar 11 9:27 PM | Dirk KerstenDirector | Sale | 177,690 | $17.72 | $3.1M | 5,285,156(I) | View → |
| Mar 6, 2026 | Mar 10 9:33 PM | Brian S PosnerDirector | Purchase | 3,000 | $15.06 | $45.2K | 11,500(D) | View → |
| Mar 5, 2026 | Mar 6 9:10 PM | Johanna Friedl-NadererChief Commercial Officer | Sale | 148 | $14.90 | $2.2K | 154,581(D) | View → |
| Mar 5, 2026 | Mar 6 9:09 PM | Douglas KerrChief Medical Officer | Sale | 904 | $14.90 | $13.5K | 171,606(D) | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Jun 9 9:15 PM | Edward HurwitzDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:13 PM | David Charles LubnerDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:13 PM | Jason P RhodesDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:12 PM | Dirk KerstenDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:12 PM | Carlo IncertiDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:09 PM | Catherine Stehman-BreenDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:06 PM | Brian S PosnerDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |